MC

Martin Cross

Dr Cross has over 35 years' experience working in the pharmaceutical and biotech industries primarily in all aspects of marketing, selling and business management. This included global roles at international headquarters of AstraZeneca and Novartis. Former Country President for Novartis Australia/NZ, Managing Director for Alphapharm (Mylan) Australia/NZ with extensive retail experience in pharmacies and Chairman of the Generics Industry Association and Medicines Australia. Other directorships in listed entities held in the previous three years include Oncosil Ltd.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
27/11/230785,95765,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
13/03/23
Issued
330,957$0.022$7,281Rights issue
01/04/21
Issued
130,000$0.075$9,750Rights issue
01/04/21
Issued
65,000$0.078$5,070Rights issue